Bibliography
- BARLOCCO D: CLX-0901 (Calyx Therapeutics). Carr. Opin. Investig. Drugs (2001) 2(5):650–653.
- NAG B, MEDICHERLA S, GOWRI MS et al.: A new anti-diabetic compound, CLX-0921: efficacy in rodent models of type II diabetes and Syndrome X. Diabetes Research and Clinical Practice (2000) 50\(Supp1.1):S344–S345.
- DEY D: Novel anti-inflammatory compounds. SMi's Third Annual Conference on Advances in Anti-Arthritic Agentsiondon, UK (2002).
- •Description of the biological profiles of some of the compounds in this programme.
Websites
- www.calyxti.com